Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder

Trial Profile

Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jun 2018

At a glance

  • Drugs Topiramate (Primary)
  • Indications Obsessive-compulsive disorders
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 25 May 2018 Status changed from recruiting to completed.
    • 26 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top